极光vn官网下载

极光vn官网下载

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

极光vn官网下载

Learn More
Folded page of a newspaper

极光vn官网下载

极光vn官网下载

Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results

极光vn官网下载

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

极光vn官网下载

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

极光vn官网下载

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

极光vn官网下载

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

极光vn官网下载

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

佛跳墙vn破解2023极光  谷歌外网加速器  Express加速器 　　  老王vnp2.2.21最新版官方  跳墙工具下载地址  letsbpn安卓下载  老王νpn最新版2.2.19  黑豹npv加速器官网